NRG Energy Inc. stock outperforms competitors on strong trading day
NRG Energy Inc. closed 8.84% short of its 52-week high of $115.38, which the company achieved on January 22nd.
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
This was the stock's second consecutive day of losses.
Stocks Are Trading Sideways in a Pivotal Week
Stocks are marking daily gains, but it's nothing to write home about as investors await an update on tariffs while readying ...
Repligen started at buy by TD Cowen, limited NIH exposure cited
TD Cowen has started coverage of Repligen (NASDAQ:RGEN) with a buy rating, citing the company's limited exposure to NIH funding cuts and China. The investment bank said Repligen (NASDAQ:RGEN) was ...
“Top-Tier”Repligen to Outperform Peers Thanks to AI and Low China Exposure
Life sciences group Repligen (RGEN) is set for healthy revenue growth, boosted by its “underappreciated” AI capabilities.Maximize Your ...
Cowen initiates Repligen stock with Buy rating, $200 target
TD Cowen began coverage on Repligen Corporation (NASDAQ:RGEN), a prominent bioprocessing company, with a Buy rating and a price target set at $200. The firm highlighted Repligen's strong position for ...
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...
Wells Fargo Sticks to Their Buy Rating for Repligen (RGEN)
Wells Fargo analyst Brandon Couillard maintained a Buy rating on Repligen (RGEN – Research Report) today and set a price target of $180.00. The ...
Repligen initiated with a Buy at TD Cowen
TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” ...
Evercore ISI Sticks to Its Buy Rating for Regeneron (REGN)
In a report released on February 7, Cory Kasimov from Evercore ISI maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...